Dr Reddy’s Laboratories on Wednesday said it has initiated a voluntary nationwide recall of all its ranitidine medications sold in the US due to contamination with probable cancer causing N-Nitrosodimethylamine (NDMA). The recall started on…
Tagged By Reddy’s
Dr Reddy’s to buy eight products In US For $350 Million
New Delhi: Dr Reddy’s Laboratories has inked a percent with Teva Pharmaceutical and an associate of Allergan percent to shop for a portfolio of eight abbreviated new drug packages (ANDAs) inside the US for $350…
Dr Reddy’s Laboratories to shop for eight capsules From Teva Pharmaceutical, shares gain
The mixed income of the branded versions of the goods inside the US is around $3.five billion, Dr Reddy’s said. extra From market Sensex Snaps four-Day dropping Streak, Ends 331 factors better Sensex Set To…
Trending News
This One Lifestyle Change Can Reduce Your Carbon Footprint by 45% – But You Won’t Like It
Google I/O 2016: Awareness API, YouTube VR App, and More Announcements
Need an Online Training Solution? Try Traind
Google Unveils venture Soli 2.0, Radar-based Gesture monitoring for Wearables, IoT
For First Time, Drone Delivers Package to US Residential Area
Apple Mac Pro Delivery Could Take Months
Karl Lagerfeld, Jean Paul Gaultier present collections at Paris Haute Couture Week 2017
Exclusive: Alyx’s Debut Men’s Collection by Designer Matthew Williams
